Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 22.3B | 16.4B | 13.5B | 13.1B |
Cost of revenue | 5.0B | 3.7B | 3.1B | 2.9B |
Gross profit | 17.3B | 12.8B | 10.4B | 10.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 1.1B | 972.2M | 750.4M |
Other operating expenses | 2.9B | 1.4B | 1.0B | 968.5M |
Operating income | 14.1B | 9.6B | 7.7B | 7.6B |
Non operating interest income | ||||
Income | — | 286.9M | 232.4M | 243.9M |
Expense | 67.4M | 62.4M | 39.7M | 38.2M |
Other income expense | — | — | — | — |
Pretax income | 16.9B | 13.5B | 9.3B | 9.9B |
Tax provision | 4.1B | 2.5B | 2.0B | 2.5B |
Net income | 12.9B | 11.1B | 7.2B | 7.4B |
Basic EPS | 20.3 | 17.7 | 11.6 | 12 |
Diluted EPS | 20.0 | 17.5 | 11.5 | 11.8 |
Basic average shares | 632.4M | 622.8M | 622.8M | 620.0M |
Diluted average shares | 632.4M | 622.8M | 622.8M | 620.0M |
EBITDA | 17.3B | 10.2B | 8.2B | 8.2B |
Net income from continuing op. | 16.9B | 13.5B | 9.3B | 9.9B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |